Workday Shares Tumble After Q1 Results, Lower Forward Guidance

Workday also announced the Defense Intelligence Agency (DIA) selected Workday Government Cloud to accelerate its human resources modernization efforts, marking Workday's formal entry into the U.S. Intelligence Community and its growth in the U.S. Federal Government market.

Workday, Inc. (NASDAQ:WDAY) reported its first-quarter financial results after the bell Thursday. Here’s a look at the details. 

The Details: Workday reported quarterly earnings of $1.74 per share which beat the analyst consensus estimate of $1.58 by 10.13%.

Quarterly sales came in at $1.99 billion which beat the analyst consensus estimate of $1.973 billion and represents an 18.17% increase over sales of $1.684 billion from the same period last year.

Workday also announced the Defense Intelligence Agency (DIA) selected Workday Government Cloud to accelerate its human resources modernization efforts, marking Workday’s formal entry into the U.S. intelligence community and its growth in the U.S. federal government market.

“Q1 was another solid quarter of revenue growth and non-GAAP operating margin expansion for Workday, as we drive toward long-term, durable growth,” said Workday CEO Carl Eschenbach.

“With the emergence of Generative AI, the shifting talent landscape, and pressure to realize operational efficiencies, Workday has never been more relevant. Our strong value proposition, investments in key growth initiatives, and leadership in AI are paying off as more organizations turn to Workday to manage their two most important assets — their people and money.”

Outlook: Workday lowered its forward guidance and now sees second-quarter subscription revenue of $1.895 billion and fiscal-year subscription revenue of between $7.7 billion and $7.725 billion.

WDAY Price Action: According to Benzinga Pro, Workday shares are down 9.16% after-hours at $237 at the time of publication Thursday.

Related News: Affirm, Paypal, Block Shares Drop Following New BNPL Regulations

Image: Shutterstock

Total
0
Shares
Related Posts
Read More

Pitney Bowes Announces Leadership Transition; Jason Dies Appointed Interim CEO; Marc Lautenbach Has Stepped Down As President, CEO And Board Member; Co Forms Committee In Search For A Permanent Successor And Support Other Value-Enhancing Initiatives

Pitney Bowes Inc. (NYSE:PBI), a global shipping and mailing company that provides technology, logistics, and financial services, today announced that the independent members of its Board of Directors (the "Board") have

PBI

Read More

Micro-Cap Avalo Therapeutics Stock Rallies As It Snaps AlmataBio For Ex-Eli Lilly Drug For Skin Disorder

Avalo Therapeutics shares are soaring after acquiring AVTX-009, a Phase 2-ready anti-IL-1β mAb. With $185 million in gross proceeds, Avalo aims to develop AVTX-009 for hidradenitis suppurativa and other chronic inflammatory indications. Chairman Garry Neil believes AVTX-009 holds immense potential in the multi-billion-dollar HS market.

AVTX